Cordon-Cardo C - Search Results

1

Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.

Ghossein RA, Osman I, Bhattacharya S, Ferrara J, Fazzari M, Cordon-Cardo C, Scher HI. Ghossein RA, et al. Diagn Mol Pathol. 1999 Jun;8(2):59-65. doi: 10.1097/00019606-199906000-00001. Diagn Mol Pathol. 1999. PMID: 10475379

2

Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.

Bazinet M, Cote RJ, Cordon-Cardo C, Myc A, Fair WR, Old LJ. Bazinet M, et al. Cancer Res. 1988 Dec 1;48(23):6938-42. Cancer Res. 1988. PMID: 2460231

3

Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma.

Armas OA, Aprikian AG, Melamed J, Cordon-Cardo C, Cohen DW, Erlandson R, Fair WR, Reuter VE. Armas OA, et al. Am J Surg Pathol. 1994 Oct;18(10):979-91. doi: 10.1097/00000478-199410000-00002. Am J Surg Pathol. 1994. PMID: 7522415 Clinical Trial.

4

Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.

Cohen DW, Simak R, Fair WR, Melamed J, Scher HI, Cordon-Cardo C. Cohen DW, et al. J Urol. 1994 Dec;152(6 Pt 1):2120-4. doi: 10.1016/s0022-5347(17)32335-2. J Urol. 1994. PMID: 7525998

5

A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.

Oliva MR, Saez GT, Latres E, Cordon-Cardo C. Oliva MR, et al. Diagn Mol Pathol. 1995 Mar;4(1):54-8. doi: 10.1097/00019606-199503000-00010. Diagn Mol Pathol. 1995. PMID: 7735557

6

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.

Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI. Sarkis AS, et al. J Clin Oncol. 1995 Jun;13(6):1384-90. doi: 10.1200/JCO.1995.13.6.1384. J Clin Oncol. 1995. PMID: 7751883

7

P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder.

Petrylak DP, Scher HI, Reuter V, O'Brien JP, Cordon-Cardo C. Petrylak DP, et al. Ann Oncol. 1994 Nov;5(9):835-40. doi: 10.1093/oxfordjournals.annonc.a059013. Ann Oncol. 1994. PMID: 7848886 Free article.

8

Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.

Dalbagni G, Presti JC Jr, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Dalbagni G, et al. Diagn Mol Pathol. 1993 Mar;2(1):4-13. Diagn Mol Pathol. 1993. PMID: 7904525

9

Bladder cancer: advances in biology and treatment.

Bosl GJ, Fair WR, Herr HW, Bajorin DF, Dalbagni G, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J, Scher HI. Bosl GJ, et al. Crit Rev Oncol Hematol. 1994 Feb;16(1):33-70. doi: 10.1016/1040-8428(94)90041-8. Crit Rev Oncol Hematol. 1994. PMID: 8074800 Review.

10

Cigarette smoking and chromosome 9 alterations in bladder cancer.

Zhang ZF, Shu XM, Cordon-Cardo C, Orlow I, Lu ML, Millon TV, Cao PQ, Connolly-Jenks C, Dalbagni G, Lianes P, Lacombe L, Reuter VE, Scher H. Zhang ZF, et al. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):321-6. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9149891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

646 results

Search Page

Filters